Brain Cancer Trial, Recruiting NCT05984888 Sponsor: Ohio State University Comprehensive Cancer Center Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT05984888
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Stage II, III, or IV breast cancer that is hormone receptor-positive (a type that responds to hormones)
  • People who are post-menopausal — meaning their periods stopped at least one year ago, or they are taking medication to suppress their ovaries, or their ovaries have been surgically removed
  • People who are within 4 weeks before or 12 weeks after starting their first main cancer treatment (such as chemotherapy, targeted therapy like CDK4/6 inhibitors, or hormone-based therapy)
  • People who are able to use the internet and take part in video calls using the Zoom platform
  • People who speak English

Who may not be able to join:

  • People who have a history of dementia, stroke, traumatic brain injury, cancer that has spread to the brain, or other conditions that may affect thinking and memory
  • People who already score higher than 8 on something called the MIND diet score — a measure of how closely someone already follows a specific brain-health eating pattern (confirm with trial site)
  • People who are unwilling or unable to eat more than 2 types of food included in the MIND diet
  • People who are currently receiving insulin therapy for diabetes
  • People who have been diagnosed with triple-negative breast cancer (a specific type of breast cancer that does not respond to hormone treatments)
  • People who are unable to give informed consent to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tonya S Orchard, PhD, Ohio State University

Phone: 800-293-5066

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University Comprehensive Cancer Center
Registry
ClinicalTrials.gov
Start date
26 October 2023
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Remote Assessment of Cognition using the Hopkins Verbal Learning Test (HVLT); Remote assessment of cognition using the WAIS-IV Digit Span; Remote assessment of cognition using the Oral Trail Making Test; Remote assessment of cognition using the COWA Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov